(Q31925596)

5 July 2017

1 reference

title

Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors (English)

1 reference

5 July 2017

Buttgereit F

1

1 reference

5 July 2017

Burmester GR

series ordinal

2

1 reference

5 July 2017

Simon LS

series ordinal

3

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

American Journal of Medicine

5 July 2017

published in

1 reference

5 July 2017

volume

110 Suppl 3A

1 reference

5 July 2017

page(s)

13S-9S

1 reference

A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Bioenergetics of immune functions: fundamental and therapeutic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900728-2

10.1016/S0002-9343(00)00728-2

7 January 2021

Identifiers

DOI

1 reference

5 July 2017

1 reference